Home » Thought Leadership » Page 5

Thought Leadership

Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 104 posts
July 6, 2020 | Blog

What’s Next for Alzheimer’s Disease?

Basic science has been redeployed to establish a new understanding of Alzheimer's Disease, focusing on novel biomarkers and cutting-edge therapeutic approaches to slow or reverse disease progression, where the amyloid beta theory has otherwise failed

ireland in pills
June 2, 2020 | Blog

2019 NRDL: Insights for Future Pricing Negotiations in China

The 2019 NRDL update offers manufacturers key learnings and insights for future NRDL negotiations, particularly with respect to the negotiation tactics used in different disease areas. CBPartners' blog post examines how these learnings can help shape future NRDL negotiations.

CBPartners' Pharma Take-Away: AMARIN's VASCEPA patent loss: is it obvious(ness)?
May 26, 2020 | Podcasts

COVID-19 (Pt 3): Testing

The final episode of the COVID-19 trilogy focuses on testing. Specifically, the different types of tests available for COVID-19 and the regulatory environment in which these tests exist.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
May 20, 2020 | Podcasts

Speaking of Access: The Management of Tumor-Agnostic Therapies

Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of tumor-agnostic therapies.

May 18, 2020 | Research posters

ISPOR Annual 2020: The Use of Integrated Delivery Networks as Pioneers for Manufacturer HEOR Program / Study Success

A research poster identifying the impact of utilizing Integrated Delivery Networks and their in-house resources in fulfilling HEOR program requirements.